President, CEO & Chairman of St. Jude Medical Inc. (STJ, Financial) Daniel J Starks sells 50,000 shares of STJ on 07/30/2009 at an average price of $38.1 a share.
St. Jude Medical Inc. is dedicated to making life better for cardiac neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management atrial fibrillation cardiac surgery cardiology and neuromodulation. St. Jude Medical Inc. has a market cap of $13.33 billion; its shares were traded at around $38.49 with a P/E ratio of 16.3 and P/S ratio of 3.1. St. Jude Medical Inc. had an annual average earning growth of 19.5% over the past 10 years. GuruFocus rated St. Jude Medical Inc. the business predictability rank of 4.5-star.
STJ is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Paulson of Paulson & Co., Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, John Hussman of Hussman Economtrics Advisors, Inc..
Recent Trades of St. Jude Medical Inc. by CEO:
Recent Trades of St. Jude Medical Inc. by CFO:
Recent Trades of St. Jude Medical Inc. by Directors and Officers:
St. Jude Medical Inc. is dedicated to making life better for cardiac neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management atrial fibrillation cardiac surgery cardiology and neuromodulation. St. Jude Medical Inc. has a market cap of $13.33 billion; its shares were traded at around $38.49 with a P/E ratio of 16.3 and P/S ratio of 3.1. St. Jude Medical Inc. had an annual average earning growth of 19.5% over the past 10 years. GuruFocus rated St. Jude Medical Inc. the business predictability rank of 4.5-star.
STJ is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Paulson of Paulson & Co., Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, John Hussman of Hussman Economtrics Advisors, Inc..
Recent Trades of St. Jude Medical Inc. by CEO:
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 shares of STJ stock on 07/28/2009 at the average price of $38.95; the price of the stock has decreased by 1.18% since.
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 more shares of STJ stock on 06/04/2009 at the average price of $40.31; the price of the stock has decreased by 4.52% since.
- Sell: President, CEO & Chairman Daniel J Starks sold 50,000 more shares of STJ stock on 06/02/2009 at the average price of $40.47; the price of the stock has decreased by 4.89% since.
- Sell: President, CEO & Chairman, Director Daniel J Starks sold 80,000 more shares of STJ stock on 02/05/2009 at the average price of $36.82; the price of the stock has increased by 4.54% since.
Recent Trades of St. Jude Medical Inc. by CFO:
- Sell: Executive VP & CFO John C Heinmiller sold 50,000 shares of STJ stock on 05/07/2009 at the average price of $35.04; the price of the stock has increased by 9.85% since.
Recent Trades of St. Jude Medical Inc. by Directors and Officers:
- Buy: Director John W Brown bought 10,000 shares of STJ stock on 05/07/2009 at the average price of $35.26; the price of the stock has increased by 9.16% since.
- Buy: President, ANS Division Christopher G Chavez bought 15,000 shares of STJ stock on 05/01/2009 at the average price of $33.17; the price of the stock has increased by 16.04% since.
- Buy: Director Barbara B Hill bought 1,450 shares of STJ stock on 04/24/2009 at the average price of $34.53; the price of the stock has increased by 11.47% since.
- Sell: President, CRMD Eric S Fain sold 52,500 shares of STJ stock on 07/24/2009 at the average price of $37.79; the price of the stock has increased by 1.85% since.
- Sell: Director Thomas H Iii Garrett sold 10,000 shares of STJ stock on 05/08/2009 at the average price of $36; the price of the stock has increased by 6.92% since.
